Index of medicine substances

Cabazitaxel  •  Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Taxanes (L01CD04)

Cabergoline  •  Genito urinary system and sex hormones | Other gynecologicals | Other gynecologicals | Prolactine inhibitors (G02CB03)

Cabotegravir  •  Antiinfectives for systemic use | Direct acting antivirals | Integrase inhibitors (J05AJ04)

Cabozantinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX07)

Caffeine citrate  •  Nervous system | Psychostimulants, agents used for adhd and nootropics | Xanthine derivatives (N06BC01)

Calcifediol  •  Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues (A11CC06)

Calcipotriol  •  Dermatologicals | Antipsoriatics | Antipsoriatics for topical use | Other antipsoriatics for topical use (D05AX02)

Calcipotriol + betamethasone  •  Dermatologicals | Antipsoriatics | Antipsoriatics for topical use | Other antipsoriatics for topical use (D05AX52)

Calcitonin  •  Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Calcitonin preparations (H05BA01)

Calcitonin (salmon)  •  Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Calcitonin preparations (H05BA01)

Calcitriol  •  Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues (A11CC04)

Calcium acetate + magnesium subcarbonate  •  Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia (V03AE04)

Calcium and magnesium glutamolactate  •  Alimentary tract and metabolism | Calcium | Calcium, combinations with vitamin d and/or other drugs (A12AXN1)

Calcium carbonate  •  Alimentary tract and metabolism | Calcium (A12AA04)

Calcium carbonate + cholecalciferol  •  Alimentary tract and metabolism | Calcium | Calcium, combinations with vitamin d and/or other drugs (A12AXN1)

Calcium carbonate + magnesium carbonate  •  Alimentary tract and metabolism | Antacids | Combinations and complexes of aluminium, calcium and magnesium compounds (A02AD01)

Calcium chloride  •  Blood and blood forming organs | I.v. solution additives | Electrolyte solutions (B05XA07)

Calcium dobesilate  •  Cardiovascular system | Antivaricose therapy | Other sclerosing agents (C05BX01)

Calcium dobesylate + lidocaine  •  Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Local anesthetics (C05AD01)

Calcium dobesylate + lidocaine + dexamethasone  •  Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Corticosteroids (C05AA09)

Calcium folate  •  Various | All other therapeutic products | All other therapeutic products | Detoxifying agents for antineoplastic treatment (V03AF03)

Calcium gluconate  •  Alimentary tract and metabolism | Calcium (A12AA03)

Calcium gluconate + calcium carbonate  •  Alimentary tract and metabolism | Calcium (A12AA20)

Calcium gluconate + calcium carbonate + ascorbic acid  •  Alimentary tract and metabolism | Ascorbic acid (vitamin C), incl. combinations | Ascorbic acid (vitamin C), combinations (A11GB01)

Calcium phosphate + cholecalciferol  •  Alimentary tract and metabolism | Other vitamin products, combinations | Vitamins with minerals (A11JBN1)

Calcium polystyrene sulfonate  •  Various | All other therapeutic products | All other therapeutic products | Drugs for treatment of hyperkalemia and hyperphosphatemia (V03AE01)

Camphor + levomenthol + eucalyptus + turpentine essential oil  •  Respiratory system | Other cold preparations (R05XN01)

Canagliflozin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins (A10BX11)

Canagliflozin + metformin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs (A10BD16)

Canakinumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Interleukin inhibitors (L04AC08)